- Home
- BMY vs CDNS Comparison
BMY vs CDNS Comparison
Compare BMY & CDNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- CDNS
- Stock Information
- Founded
- BMY 1887
- CDNS 1988
- Country
- BMY United States
- CDNS United States
- Employees
- BMY N/A
- CDNS N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- CDNS Computer Software: Prepackaged Software
- Sector
- BMY Health Care
- CDNS Technology
- Exchange
- BMY Nasdaq
- CDNS Nasdaq
- Market Cap
- BMY 97.6B
- CDNS 86.1B
- IPO Year
- BMY N/A
- CDNS 1987
- Fundamental
- Price
- BMY $46.87
- CDNS $295.40
- Analyst Decision
- BMY Hold
- CDNS Buy
- Analyst Count
- BMY 16
- CDNS 13
- Target Price
- BMY $58.33
- CDNS $325.62
- AVG Volume (30 Days)
- BMY 11.9M
- CDNS 2.1M
- Earning Date
- BMY 07-31-2025
- CDNS 07-21-2025
- Dividend Yield
- BMY 5.29%
- CDNS N/A
- EPS Growth
- BMY N/A
- CDNS 2.60
- EPS
- BMY 2.67
- CDNS 3.94
- Revenue
- BMY $47,636,000,000.00
- CDNS $4,874,527,000.00
- Revenue This Year
- BMY N/A
- CDNS $13.96
- Revenue Next Year
- BMY N/A
- CDNS $11.74
- P/E Ratio
- BMY $17.55
- CDNS $74.98
- Revenue Growth
- BMY 4.62
- CDNS 19.55
- 52 Week Low
- BMY $39.35
- CDNS $221.56
- 52 Week High
- BMY $63.33
- CDNS $328.99
- Technical
- Relative Strength Index (RSI)
- BMY 40.79
- CDNS 45.52
- Support Level
- BMY $46.39
- CDNS $297.03
- Resistance Level
- BMY $50.76
- CDNS $304.44
- Average True Range (ATR)
- BMY 0.98
- CDNS 5.99
- MACD
- BMY -0.10
- CDNS -1.17
- Stochastic Oscillator
- BMY 10.98
- CDNS 38.95
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About CDNS Cadence Design Systems Inc.
Cadence Design Systems is a provider of electronic design automation software, intellectual property, and system design and analysis products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Cadence offers a portfolio of design IP, as well as system design and analysis products, which enables system-level analysis and verification solutions.